Emera Incorporated EMA
Set alert
At close · Oct 30
After hours · Oct 30, 5:26 PM ET
- YTD
- +0.10%
- 1 year
- +1.73%
- Open
- 49.25
- Prev close
- 48.85
- Mkt cap
- 15.14B
- Vol
- 466.10K
- Avg vol
- 755.59K
- EPS
- 2.29
- P/E
- 21.52
- Div yield
- 4.29%
More statistics
- Low
- 49.16
- High
- 49.56
- Forward P/E
- 19.03
- Beta
- 0.42
- Short ratio
- 13.80
- Inst. own
- 57.09%
- Dividend
- 2.12
- Ex-div date
- Oct 29, 2026
- Earnings
- Nov 6, 2026
- 50-d avg
- 48.60
- 200-d avg
- 51.19
- 1y target
- 50.00
5D chart
Events in this range
- Oct 30, 2026Dividend: 0.74
Signals (117)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 4:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:55 PM | 2 days ago |
| RSI: Oversold | Oct 30, 3:40 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:15 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 1:20 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:35 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:05 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:55 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 11:20 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:10 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:05 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:00 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:35 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 10:35 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:15 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:10 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:10 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:45 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:40 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:50 PM | 3 days ago |
| RSI: Overbought | Oct 29, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:35 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 11:55 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:15 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:10 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:20 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:05 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:45 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 4 days ago |
| RSI: Oversold | Oct 28, 2:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:10 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:40 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:05 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 4 days ago |
| RSI: Overbought | Oct 27, 3:45 PM | 5 days ago |
| RSI: Overbought | Oct 27, 3:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:55 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:30 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:55 PM | 5 days ago |
| RSI: Oversold | Oct 27, 12:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:40 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:35 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:05 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:05 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:05 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:55 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:50 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:20 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:20 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:20 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:10 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:00 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:25 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:10 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:45 PM | 6 days ago |
| RSI: Overbought | Oct 26, 1:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:35 PM | 6 days ago |
| RSI: Oversold | Oct 26, 11:35 AM | 6 days ago |
| RSI: Oversold | Oct 26, 10:50 AM | 6 days ago |
News
5 days ago defenseworld.net
Crossmark Global Holdings Inc. Buys 21,825 Shares of eMagin Corporation $EMA
Crossmark Global Holdings Inc. acquired a new stake in eMagin Corporation (NYSE: EMA) in the third quarter, according to its most recent filing with the SEC. The fund acquired 21,825 shares of the…
6 days ago gurufocus.com
Pfizer's TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment Setting
[url="]Pfizer Inc. (NYSE: PFE)[/url] today announced that the U.S. Food and Drug Administration (FDA) has expanded approval of TALZENNAÂ (talazoparib) in combi
-
1 week ago benzinga.com
Barclays Maintains Equal-Weight on Emera, Lowers Price Target to $50
Barclays analyst Nicholas Campanella maintains Emera (NYSE:EMA) with a Equal-Weight and lowers the price target from $53 to $50.
2 weeks ago gurufocus.com
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
SKYRIZIÂ (risankizumab) and RINVOQÂ (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2
2 weeks ago defenseworld.net
Emera Incorporated (EMA.TO) – What Are Researchers Saying About This Stock?
Emera Incorporated (TSE: EMA - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine research firms that are covering the company, Marketbeat reports. Three…
2 weeks ago benzinga.com
Top 3 Utilities Stocks Which Could Rescue Your Portfolio This Month
Deep Fission, Emera and VivoPower are oversold utilities stocks with RSI readings near or below 30, presenting potential buying opportunities.
2 weeks ago businesswire.com
Emera Declares Quarterly Dividends
HALIFAX, Nova Scotia--(BUSINESS WIRE)--On October 13, 2026, the Board of Directors of Emera Inc. (TSX/NYSE: EMA) declared quarterly dividends on its common shares and First Preferred Shares, each of…
3 weeks ago businesswire.com
Emera Teleconference on November 6 to Discuss Q3 2026 Results and 2027-2031 Capital Plan
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Today Emera (TSX/NYSE: EMA) announced that it will release its Q3 2026 results and outline its 5-year capital and funding plan on Friday, November 6, 2026,…
3 weeks ago defenseworld.net
Emera (NYSE: EMA) agrees $72 billion merger with Canadian Utilities and ATCO spin-off
What happened Emera (NYSE: EMA), Canadian Utilities and ATCO agreed on Oct. 6, 2026, to combine in a merger of equals. The combined company is expected to have approximately $72 billion in pro forma…
3 weeks ago proactiveinvestors.com
Emera to combine with Canadian Utilities in largest all-Canadian merger on record
Emera and Canadian Utilities (TSX:CU) have agreed to merge, creating a Canadian utility and energy infrastructure company with a pro forma enterprise value of about $72 billion, the companies said on…
3 weeks ago marketbeat.com
Canadian Utilities, Emera Strike C$72B Utility Merger Deal
Emera and Canadian Utilities TSE: CU have agreed to combine in a predominantly all-share transaction that the companies said would create a Canadian-headquartered, top-20 North American regulated…
3 weeks ago marketbeat.com
Emera, Canadian Utilities Unveil C$72B Merger to Create Utility Powerhouse
Emera TSE: EMA and Canadian Utilities have agreed to combine in a predominantly all-share transaction that the companies said would create a top-20 North American utility and energy infrastructure…
3 weeks ago defenseworld.net
Emera, Canadian Utilities Unveil C$72B Merger to Create Utility Powerhouse
Emera (TSE: EMA) and Canadian Utilities have agreed to combine in a predominantly all-share transaction that the companies said would create a top-20 North American utility and energy infrastructure…
3 weeks ago businesswire.com
Emera, ATCO and Canadian Utilities Announce Transformational Agreement to Create Canadian Utility and Energy Infrastructure Powerhouse
HALIFAX, Nova Scotia & CALGARY, Alberta--(BUSINESS WIRE)--Emera, ATCO and Canadian Utilities today announced a definitive agreement to bring together Emera and Canadian Utilities in a merger of…
1 month ago businesswire.com
Emera Announces Increase in Common Dividend
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (TSX/NYSE: EMA) today announces that its Board of Directors have approved an increase in the company's quarterly dividend on its common share to…
1 month ago defenseworld.net
Emera Incorporated (TSE:EMA) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Emera Incorporated (TSE: EMA - Get Free Report) have earned an average rating of "Moderate Buy" from the nine analysts that are currently covering the firm, MarketBeat.com reports. Three…
1 month ago gurufocus.com
Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform
Arcturus Therapeutics Holdings Inc. (the âCompanyâ, âArcturusâ, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and
1 month ago defenseworld.net
Engineers Gate Manager LP Purchases 17,165 Shares of eMagin Corporation $EMA
Engineers Gate Manager LP lifted its position in shares of eMagin Corporation (NYSE: EMA) by 182.6% in the second quarter, according to the company in its most recent disclosure with the Securities…
1 month ago gurufocus.com
Extreme Delivers Industry's First Proactive, Context-Aware AI Agent for Networking
[url="]Extreme Networks[/url], Inc. (NASDAQ: EXTR) today announced the general availability of [url="]Extreme Agent ONE⢠Coworker[/url], the next generation o
2 months ago gurufocus.com
Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia PR Newswire
2 months ago gurufocus.com
Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the Marketing
2 months ago prnewswire.com
Bernhard Capital Partners Completes Acquisition of New Mexico Gas Company
BATON ROUGE, La., Aug. 12, 2026 /PRNewswire/ -- Bernhard Capital Partners ("Bernhard"), an infrastructure and services-focused private markets investment firm, announced today that it has closed on…
-
2 months ago benzinga.com
Barclays Maintains Equal-Weight on Emera, Lowers Price Target to $53
Barclays analyst Michael Lonegan maintains Emera (NYSE:EMA) with a Equal-Weight and lowers the price target from $55 to $53.
-
2 months ago benzinga.com
Emera Q2 Adj. EPS $0.50 Misses $0.56 Estimate, Sales $1.453B
Emera (NYSE:EMA) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.56 by 10.71 percent. The company reported $1.453 billion in sales this quarter.
-
2 months ago benzinga.com
Emera Q2 Adj. EPS $0.50 Misses $0.56 Estimate
Emera (NYSE:EMA) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.56 by 10.71 percent.
-
5 months ago benzinga.com
Barclays Maintains Equal-Weight on Emera, Lowers Price Target to $52
Barclays analyst Michael Lonegan maintains Emera (NYSE:EMA) with a Equal-Weight and lowers the price target from $53 to $52.
-
5 months ago benzinga.com
Emera Q1 Adj. EPS $1.00 Beats $0.89 Estimate, Sales $2.051B
Emera (NYSE:EMA) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.89 by 12.36 percent. The company reported $2.051 billion in sales this quarter.
-
5 months ago benzinga.com
Emera Q1 Adj. EPS $1.00 Beats $0.89 Estimate
Emera (NYSE:EMA) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.89 by 12.36 percent.
6 months ago benzinga.com
This Rambus Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
Wall Street analysts changed outlook on top names. Check analyst ratings page for full view. See what experts think about RMBS stock.
6 months ago benzinga.com
This Micron Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Top Wall Street analysts changed outlooks on top stocks. Check out our analyst ratings page for upgrades, downgrades, and initiations.
-
6 months ago benzinga.com
Barclays Initiates Coverage On Emera with Equal-Weight Rating, Announces Price Target of $53
Barclays analyst Michael Lonegan initiates coverage on Emera (NYSE:EMA) with a Equal-Weight rating and announces Price Target of $53.
-
8 months ago benzinga.com
Emera Q4 Adj. EPS $0.39 Misses $0.43 Estimate, Sales $1.439B
Emera (NYSE:EMA) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.43 by 9.3 percent. The company reported $1.439 billion in sales this quarter.
8 months ago benzinga.com
Earnings Scheduled For February 23, 2026
Earnings Scheduled For February 23, 2026
-
11 months ago benzinga.com
Emera Renews C$600 Million At-The-Market Equity Program, Extending Financing Flexibility Through 2029
Emera Incorporated ("Emera" or the "Company") (NYSE:EMA) announced today that it has renewed its at-the-market equity program (the "ATM Program") that allows the Company to issue up to C$600,000,000…
11 months ago benzinga.com
Earnings Scheduled For November 7, 2025
Earnings Scheduled For November 7, 2025